SLC2A1 and neoplasm: LncRNA NBR2 promoted protein kinase AMP-activated catalytic subunit alpha 1 (AMPK) pathway to down-regulate GLUT1 expression and the EMT process, suppressed tumor progression in osteosarcoma cells (Liu and Gan, 2016).